Who owns PBLS?
Institutional ownership of Parabilis Medicines Inc. from Form 13F, Q2 2026
79 institutional managers reported holding Parabilis Medicines Inc. (PBLS) in Form 13F filings for Q2 2026, with 98,966,433 shares worth $2.7B. The largest reported holder was Ra Capital Management, L.p. 78 opened new positions and 0 sold out.
- Funds holding
- 79
- Value held
- $2.7B
- New / sold out
- 78 / 0
- Net shares, same filers
- None
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of PBLS
Share of 13F holdings is each fund's shares as a share of the 98,966,433 PBLS shares all 13F filers reported, not of shares outstanding.
Questions about PBLS ownership
- Who owns PBLS stock?
- 79 institutional investment managers reported PBLS positions in their Form 13F filings for Q2 2026, holding 98,966,433 shares worth $2.7B in total. Ra Capital Management, L.p. reported the largest position.
- Are funds buying or selling PBLS?
- 78 managers opened new PBLS positions in Q2 2026.
- How current is this PBLS institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to PBLS by CUSIP. Options are left out. PBLS news and filings · PBLS insider trades · Top funds